Diana Shipping Inc. has criticized Genco Shipping & Trading for changing its valuation methods to avoid engaging with Diana's $24.80 per share all-cash takeover offer. Diana argues it has consistently offered around 1.0x NAV based on broker valuations Genco used previously, while Genco now uses new, unproven methods and demands an unjustified control premium. Diana calls for an independent valuation process, removal of Genco's poison pill, and urges shareholders to vote for Diana's nominees and accept the offer. The dispute highlights tensions over fair valuation and control, with Diana warning shareholders of potential share price declines if the offer is rejected.
The HON Company has launched a new 12,000-square-foot flagship showroom in Chicago, designed as an immersive workplace and learning environment. The showroom integrates HON's portfolio across four zones—The Commons, The Sandbox, The Hub, and The Educ...
Medtronic reported adjusted earnings of $1.55 per share, slightly above estimates, and revenue rose 9.9% year-over-year to $9.81 billion, driven by strong cardiovascular segment growth. BTIG upgraded Medtronic from Neutral to Buy, citing accelerating...
The global market for non-invasive blood glucose monitoring devices, which measure blood sugar without needles, is projected to grow from $34.86 million in 2024 to $340.49 million by 2034, at a CAGR of 25.6%. Growth is fueled by the increasing diabet...
IBM has formed a strategic partnership with Google Cloud to accelerate AI adoption across industries like banking, retail, and telecom by launching a joint Google Cloud Practice. The collaboration aims to help customers deploy and manage AI at scale ...
DelveInsight reports over 12 companies developing IgE receptor antagonists for allergic conditions like asthma and chronic urticaria. Key drugs such as ADL-018 and LP-003 are in late-stage trials, showing promise against existing treatments like Xola...
